Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background. Mortality from cerebrovascular diseases in Russia is one of the highest in the world. Aim. To determine trends in the incidence of cerebrovascular pathology, including in connection with the pandemic of the new coronavirus infection COVID-19. Material and methods. The structure, indicators of primary and general incidence of cerebrovascular pathology in 2010–2022 in Russia as a whole according to statistical observation form No. 12 were analyzed. Intensive, extensive, and standardized indicators were calculated and regression analysis was performed. Results. The share of newly diagnosed cerebrovascular diseases in the structure of circulatory system diseases in Russia during the study period decreased from 21.7 to 17.4%. The overall incidence of cerebrovascular pathology ranged from 4371.1 to 4938.1, primary — from 599.8 to 791.2 per 100 thousand population. The primary incidence rate of stroke in the period from 2010 to 2019 increased from 270.1 to 296.6 per 100 thousand population, with a subsequent decrease in 2022 to 275.3 per 100 thousand population. When standardizing the primary incidence of stroke by age, no significant changes in the indicator were detected over the entire observation period. During the COVID-19 pandemic, the incidence of cerebrovascular diseases (general and primary), as well as the incidence of their individual units, decreased or deviated from the upward trend. The proportion of strokes not specified as hemorrhage or infarction decreased from 10.2 to 1.8%. During the pandemic period (2020–2022), there was an increase in the risk of developing cerebral infarction compared to intracranial and intracerebral hemorrhages (from 1.7:1 to 1.9:1; p=0.0000). The primary incidence of hemorrhagic and ischemic strokes increased from 161.3 (2010) to 238.1 (2019) per 100 thousand population; in 2022 it was 225.7 per 100 thousand population. During the study period, there was no trend towards an increase in the standardized incidence of strokes. Conclusion. From 2010 to 2019 in Russia there was an increase in the primary incidence of cerebrovascular pathology, a decrease in overall and primary incidence in 2020–2022.
Background. Mortality from cerebrovascular diseases in Russia is one of the highest in the world. Aim. To determine trends in the incidence of cerebrovascular pathology, including in connection with the pandemic of the new coronavirus infection COVID-19. Material and methods. The structure, indicators of primary and general incidence of cerebrovascular pathology in 2010–2022 in Russia as a whole according to statistical observation form No. 12 were analyzed. Intensive, extensive, and standardized indicators were calculated and regression analysis was performed. Results. The share of newly diagnosed cerebrovascular diseases in the structure of circulatory system diseases in Russia during the study period decreased from 21.7 to 17.4%. The overall incidence of cerebrovascular pathology ranged from 4371.1 to 4938.1, primary — from 599.8 to 791.2 per 100 thousand population. The primary incidence rate of stroke in the period from 2010 to 2019 increased from 270.1 to 296.6 per 100 thousand population, with a subsequent decrease in 2022 to 275.3 per 100 thousand population. When standardizing the primary incidence of stroke by age, no significant changes in the indicator were detected over the entire observation period. During the COVID-19 pandemic, the incidence of cerebrovascular diseases (general and primary), as well as the incidence of their individual units, decreased or deviated from the upward trend. The proportion of strokes not specified as hemorrhage or infarction decreased from 10.2 to 1.8%. During the pandemic period (2020–2022), there was an increase in the risk of developing cerebral infarction compared to intracranial and intracerebral hemorrhages (from 1.7:1 to 1.9:1; p=0.0000). The primary incidence of hemorrhagic and ischemic strokes increased from 161.3 (2010) to 238.1 (2019) per 100 thousand population; in 2022 it was 225.7 per 100 thousand population. During the study period, there was no trend towards an increase in the standardized incidence of strokes. Conclusion. From 2010 to 2019 in Russia there was an increase in the primary incidence of cerebrovascular pathology, a decrease in overall and primary incidence in 2020–2022.
The purpose of the study was to evaluate the possibilities of MRI in determining the stage of hemorrhagic stroke (HS) depending on structural and perifocal changes in children.Materials and methods. The study included 46 patients (including 19 boys and 27 girls) aged from the 29th day of life to 18 years, with a clinical picture of cerebrovascular accident and the presence of HS in the brain substance (BS) during an MRI study. For statistical analysis, patients were divided into two groups: group 1 – patients examined in the first 48 hours from the onset of neurological symptoms (21 people), group 2 – after 48 hours (26 people). Comparison in two groups was carried out according to MR signs: the presence of perifocal cytotoxic edema, the presence of perifocal hemorrhagic impregnation, the presence of a cytoplasmic rim. Intergroup comparisons on a qualitative basis were carried out using Fisher's exact test.Results. As a result of the study, differential diagnostic criteria for the stages of HS in children were determined by analyzing the MRI semiotics of hematoma in combination with the symptom complex of perifocal changes (CPC) in the form of perifocal cytotoxic edema, perifocal hemorrhagic impregnation and cytoplasmic rim. Statistically significant differences in the frequency of occurrence of signs of perifocal cytotoxic edema and perifocal hemorrhagic impregnation in the groups were found. The presence of perifocal cytotoxic edema was statistically significant (p = 0.027) more common in group 1 (47% (n = 10), 95% CI 26–69) than in group 2 (16% (n = 4), 95% CI 5–36). The presence of perifocal hemorrhagic soaking was statistically significantly (p = 0.003) more common in group 1 (81% (n = 17), 95% CI 57–93) than in group 2 (36% (n = 9), 95% CI 18–57). In addition, a statistically significant (p = 0.005) difference was found in the incidence of CPC, which was observed in group 1 (28% (n = 6), CI 12–52) and was not observed in group 2 (0%, (n = 0), 95% CI 0–17).Conclusions. The use of T2, T1, FLAIR, SWI and DWI modes (b = 1000) in combination with ADC in the protocol of MRI examination of children is mandatory, and only a comparison of the characteristics of the MR signal from a hematoma in combination with an analysis of perifocal changes allows us to differentiate the stage of hemorrhage. HS in the acute and early subacute stages has a similar MRI semiotics, therefore, it is necessary to assess the complex of perifocal changes, which allows to differentiate these stages, as it is determined in patients examined in the first 48 hours (p < 0.05) and is not observed after two days. SWI analysis makes it possible to differentiate the late subacute stage of hematoma from chronic due to different characteristics of the MR signal, and also allows you to establish the presence of perifocal hemorrhagic impregnation, which contributes to the differential diagnosis of hemorrhage in the early stages of the pathological process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.